caracemide has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blough, R; Carroll, R; Chernicoff, D; Lad, T; Mullane, M; Schor, J; Weidner, L | 1 |
Aisner, J; Belani, CP; Eisenberger, M; Hiponia, D; Van Echo, D | 1 |
1 trial(s) available for caracemide and Lung Neoplasms
Article | Year |
---|---|
Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Hydroxyurea; Lung Neoplasms; Male; Middle Aged | 1992 |
1 other study(ies) available for caracemide and Lung Neoplasms
Article | Year |
---|---|
Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Hydroxyurea; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 1987 |